Prostate cancer
Conditions
Interventions
During the prostatectomy, subsequent to the prostate removal and achieving
satisfactory hemostasis, abundant tissue is excised on the non-nerve-sparing
side(s) surrounding the area previously occupi
Sponsors
Antoni van Leeuwenhoek Ziekenhuis
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Undergoing a non-nerve-sparing robot assisted laparoscopic radical prostatectomy (unilateral or bilateral non-nerve-sparing). Any value of prostate-specific antigen (PSA). Any grade from the International Society of Urological Pathology (ISUP). Any tumor (T) stage on the magnetic resonance imaging (MRI) scan.
Exclusion criteria
Exclusion criteria: Molecular Imaging (MI), specifically on PSMA-PET, a lymph node (N) stage 1 Salvage prostatectomy NeuroSAFE procedure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The count of positive surgical margins among patients undergoing RARP for prostate cancer, wherein exision of abundant tissue was conducted during the RARP procedure. | — |
Secondary
| Measure | Time frame |
|---|---|
| - To evaluate the incidence of complications (rectal injury and postoperative bleeding) among patients who have undergone the Resect SAFE procedure. - To determine the rate of biochemical recurrence (at 6 months and 1 year) within the cohort of patients subjected to the Resect SAFE procedure | — |
Countries
Netherlands
Outcome results
None listed